You are currently browsing:

Lobular breast cancer comes into the research spotlight

Breast Cancer Ireland fully supports new research being undertaken by Fred Hutch (aka the Fred Hutchinson Cancer Research Center, based in Seattle, USA) into lobular breast cancer, which accounts for 10%-15% of invasive breast cancers. It is harder to detect and generally understudied, which is why this research is so important. For further details, please […]

Read More

Antibody discovery offers breakthrough in breast cancer fight

A research team at King’s College London has found that “targeted antibody therapies could bring long-awaited advances for those with triple-negative breast cancer.” Breakthroughs like these are exactly why breast cancer research is so important. To read more on this, please click the below link: https://bit.ly/2GZSEvo

Read More

DPYSL3 an outlier gene in triple-negative breast cancer

Breast Cancer Ireland is delighted with new research from Baylor College of Medicine (based in Houston, Texas, USA) that highlights DPYSL3 as an outlier gene in triple-negative breast cancer. It is typically associated with younger women diagnosed and for whom traditional standard treatments are generally prescribed. There is a great need for continued investment into […]

Read More

Seasonal Style, Beauty and Inspiration Supporting Breast Cancer Ireland

A host of well-known faces from the world of fashion, beauty and broadcasting, along with breast cancer survivors and supporters, gathered in Marco Pierre White Courtyard Bar & Grill in Donnybrook, Dublin on Friday, December 7, to raise funds to support Breast Cancer Ireland’s research and awareness programmes nationally. The second annual Beauty, Style & […]

Read More
X